open access

Vol 9, No 5 (2005)
Artykuły redakcyjne
Published online: 2005-09-29
Get Citation

Nephrolithiasis and arterial hypertension

Marek Kretowicz, Jacek Manitius
Nadciśnienie tętnicze 2005;9(5):327-334.

open access

Vol 9, No 5 (2005)
Artykuły redakcyjne
Published online: 2005-09-29

Abstract

Nephrolithiasis is a general, chronic metabolic disease which is characterized by producing renal deposits which come from normal or abnormal urine components. Nephrolithiasis occurs frequently in population studies results: 2% in Poland. Arterial hypertension occurs in 29% of polish population. Nephrolithiasis is related with the high risk of future hypertension. On the other hand the patients with nephrolithiasis are more often hypertensive than general population. It is suggested that hypertension and nephrolithiasis have common roots in particular: the insulin resistance state.
Among underestimated prolithogenic elements, besides the hypercalciuria which should be treated as an important screening factor, there are some hypotensive drugs: beta-blockers, diuretics and ACE inhibitors which may cause nephrolithiasis.
There is a suggestion that nephrolithiasis and hypertension at least partially demonstrate common metabolic disturbances, they are both risk factor and a result to each other, but no such statement is mentioned in JNC VII, ESH-ESC, PTNT.

Abstract

Nephrolithiasis is a general, chronic metabolic disease which is characterized by producing renal deposits which come from normal or abnormal urine components. Nephrolithiasis occurs frequently in population studies results: 2% in Poland. Arterial hypertension occurs in 29% of polish population. Nephrolithiasis is related with the high risk of future hypertension. On the other hand the patients with nephrolithiasis are more often hypertensive than general population. It is suggested that hypertension and nephrolithiasis have common roots in particular: the insulin resistance state.
Among underestimated prolithogenic elements, besides the hypercalciuria which should be treated as an important screening factor, there are some hypotensive drugs: beta-blockers, diuretics and ACE inhibitors which may cause nephrolithiasis.
There is a suggestion that nephrolithiasis and hypertension at least partially demonstrate common metabolic disturbances, they are both risk factor and a result to each other, but no such statement is mentioned in JNC VII, ESH-ESC, PTNT.
Get Citation

Keywords

nephrolithiasis; hypertension; metabolism

About this article
Title

Nephrolithiasis and arterial hypertension

Journal

Arterial Hypertension

Issue

Vol 9, No 5 (2005)

Pages

327-334

Published online

2005-09-29

Bibliographic record

Nadciśnienie tętnicze 2005;9(5):327-334.

Keywords

nephrolithiasis
hypertension
metabolism

Authors

Marek Kretowicz
Jacek Manitius

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl